• Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis
  • Brucella Antibody, IgG and IgM
  • Lead/Creatinine Ratio, Random, Urine
  • Sphingomyelin Phosphodiesterase 1 (SMPD1) Mutation Analysis, Niemann-Pick Disease
  • Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
  • Thrombin Time
  • Valproic Acid, Free and Total, Serum
  • Hereditary Hemolytic Anemia Gene Mutation Panel, NGS
  • Nordiazepam, Urine
  • Fibroblast Growth Factor 23 (FGF23), Plasma
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Fragile X, FMR1 Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Fragile X, FMR1 Gene Mutation Analysis
Medical Test

Clinical Utility
Access to Fragile X, FMR1 Gene Mutation Analysis is restricted.